
937 Superiority of aprepitant, an oral NK1 antagonist, over standard antiemetic therapy: Reducing the impact of nausea and vomiting on patients' daily lives
A.R. Martin, G.J. Ma, A.D. Carides, K. Horgan, F. Lawson, M. Elmer, C. Schmidt, C.M. Lindley, M. AaproVolume:
1
Année:
2003
Langue:
english
DOI:
10.1016/s1359-6349(03)90964-5
Fichier:
PDF, 172 KB
english, 2003